| Organism name | Epimedium spp. |
|---|---|
| Genus | Epimedium |
| Family | Berberidaceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Epimedium |
|---|---|
| Linked NCBI taxonomy ID | 63350 |
| Linked level | genus |
| Family in NCBI taxonomy | Berberidaceae |
|---|---|
| ID | 41773 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | eudicotyledons |
|---|---|
| ID | 71240 |
| Species | Activity |
|---|---|
| Epimedium spp. | Antiaggregant |
| Epimedium spp. | Antiarthritic |
| Epimedium spp. | Antibacterial |
| Epimedium spp. | Anticancer |
| Epimedium spp. | Antiglucocorticoid |
| Epimedium spp. | Antiinflammatory |
| Epimedium spp. | Antiosteoporotic |
| Epimedium spp. | Antirheumatic |
| Epimedium spp. | Antiseptic |
| Epimedium spp. | Antitussive |
| Epimedium spp. | Antiviral |
| Epimedium spp. | Aphrodisiac |
| Epimedium spp. | Cardioprotective |
| Epimedium spp. | Catacholamine Inhibitor |
| Epimedium spp. | Expectorant |
| Epimedium spp. | Fibrinolytic |
| Epimedium spp. | Hepatoprotective |
| Epimedium spp. | Hypotensive |
| Epimedium spp. | Immunomodulator |
| Epimedium spp. | Immunostimulant |
| Epimedium spp. | Leukocytogenic |
| Epimedium spp. | Memorigenic |
| Epimedium spp. | Osteogenic |
| Epimedium spp. | Phagocytotic |
| Epimedium spp. | Proaggregant |
| Epimedium spp. | Spermatogenic |
| Epimedium spp. | Tonic |
| Epimedium spp. | Vasodilator |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00005811
|
Epimedoside A
|
C092397
|
No. 1 | No. 15 |
|
|||
|
C00005824
|
Icariin
|
CHEMBL553204
CHEMBL1515685 CHEMBL2308655 |
C056599
|
6 / 1 / 1 | 6 / 9 | No. 1 | No. 15 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P06746 | DNA polymerase beta | Enzyme | C00005824 | 0 / 0 |
| O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00005824 | 0 / 0 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00005824 | 0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00005824 | 0 / 0 |
| P51160 | Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | PDE_6C | C00005824 | 1 / 1 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00005824 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 650 | BMP2, BDA2, BMP2A | bone morphogenetic protein 2 |
C00005824
|
| 4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00005824
|
| 8654 | PDE5A, CGB-PDE, CN5A, PDE5 | phosphodiesterase 5A, cGMP-specific (EC:3.1.4.35) |
C00005824
|
| 5241 | PGR, NR3C3, PR | progesterone receptor |
C00005824
|
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00005824
|
| 7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00005824
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D000544 | Alzheimer Disease |
C00005824
|
| D001284 | Atrophy |
C00005824
|
| D001847 | Bone Diseases |
C00005824
|
| D002545 | Brain Ischemia |
C00005824
|
| D004487 | Edema |
C00005824
|
| D007172 | Erectile Dysfunction |
C00005824
|
| D007859 | Learning Disorders |
C00005824
|
| D008569 | Memory Disorders |
C00005824
|
| D010024 | Osteoporosis |
C00005824
|